Skip to main content
Premium Trial:

Request an Annual Quote

Illumina, North American Rheumatoid Arthritis Consortium Pen Genotyping Study Agreement

NEW YORK, Sept. 16 (GenomeWeb News) - Illumina signed an agreement to collaborate on a rheumatoid arthritis genotyping study with the North American Rheumatoid Arthritis Consortium, the company said today.


The study involves the analysis of 3,125 samples using Illumina's Linkage IV SNP panel with its BeadArray platform. NARAC researchers will analyze the data in hopes of identifying genes associated with rheumatoid arthritis, Illumina said. 


The effort is led by Peter Gregersen, director of the RobertS.BoasCenter for Genomics and Human Genetics at the Institute for Medical Research in Manhasset, NY. Gregersen is also the principal investigator of the Multiple Autoimmune Disease Genetics Consortium, an effort by the US National Institutes of Health effort to identify genes linked to autoimmune diseases.


The company declined to disclose financial details of the deal.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more